David T. Howton, SVP at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 328 shares at $44.29 ($15K) on 2011-09-01, disclosed to the SEC on 2011-09-07.
Scheduled sale ($15k) by SVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SLDB | SELL | 2026-02-02 | $486K | — | Filing → |
| SLDB | SELL | 2025-12-04 | $25K | — | Filing → |
| SLDB | SELL | 2025-02-18 | $22K | — | Filing → |